Grants

Home Grants

INSTITUTIONAL GRANTS

NO. GRANT TITLE FUNDER
1. Platform for Controlled Human Malaria Infection (CHMI) studies for development of new malaria vaccines, drugs and diagnostics in Africa European Developing  Countries Clinical Trials Partnership
2. Establishment of Institutional Review board at the Center for Research in Therapeutic Sciences European Developing  Countries Clinical Trials Partnership
3. Establishment of the Center for Excellence for Research in Therapeutic Sciences Consortium for National Health Research
4. Development of Nanomedicine Drug Delivery Systems (NMDDS) in the treatment of Malaria

 

National Council for Science and Technology and National Research Foundation
5. Resource establishment at the  Centre for Research in Therapeutic Sciences INDEPTH  Network
6. Infrastructure upgrade of the Clinical Trials Facility at KEMRI INDEPTH  Network and Malaria Clinical Trials Alliance
7. Pilot Pharmaco-Epidemiology of Hypertension Therapeutics in Selected Health Facilities in Nairobi Glaxo SmithKline
8. Establishment of pharmacology and therapeutic Unit at the centre of excellence for clinical trials and therapeutics(supplementary grant) Consortium for National Health Research
9. The effects of Zinc supplementation in children with sickle cell disease in Western Kenya: a pilot study

 

Glaxo SmithKline
10. An open-label, non-randomized, single dose study of pharmacokinetics, safety and tolerability of Captopril in healthy Kenyan Adults Novartis

 

  STUDY GRANTS

NO. FUNDER
1. Genetic characterization of HIV-1 strains circulating in Kenya and determination of known mutations conferring resistance to antiretroviral drugs Consortium for National Health Research
2. Towards malaria elimination in tropical Africa: A molecular epidemiological survey of Plasmodium falciparum on islands in Lake Victoria Consortium for National Health Research
3. Evaluation of nano-formulated antimalarials Consortium for National Health Research
4. An open-label clinical trial of pharmacokinetics of artemether-lumefantrine in pregnant and non-pregnant women with uncomplicated Plasmodium falciparum  malaria in Kenya Consortium for National Health Research
5. Profiling antibody immune responses in infants and children vaccinated with RTS,S/AS01E malaria vaccine in Kisumu, Western Kenya Consortium for National Health Research
6. Determining the molecular diversity and drug resistance profiles of HIV, HBV and HCV in co-infected HIV positive intravenous drug users AstraZenaca Pharmaceuticals (Pty) Limited